Profile photo Lois Daamen

Lois Daamen

Associate Professor

Strategic program(s):

Strategic program(s):

Contact

Research groups

Evaluation of imaging and image-guided Interventions

Research aim

The pace of innovation in (AI driven) imaging/image-guided interventions in oncology is high; the window of opportunity for evaluation narrow. We aim to learn from every patient, in order to facilitate evidence-based implementation of innovation.

Go to group

Recent publications

Recognizing IPMN-derived pancreatic cancer as a specific entity requiring prospective clinical studies Joseph R. Habib, Ammar A. Javed, I. Quintus Molenaar, Christopher L. Wolfgang, Marc G. Besselink, Camila Hidalgo Salinas, Ingmar F. Rompen, Brady A. Campbell, D. Brock Hewitt, Lois A. Daamen, Greg D. Sacks, Katherine Morgan, Jin He,
Journal of the National Cancer Institute, 2025, vol. 117, p.1084-1085
Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic adenocarcinoma Merlijn U J E Graus, Aniek E van Diepen, Kim Josemanders, Marc G Besselink, Stefan A W Bouwense, Lois A Daamen, Ignace H J T de Hingh, Evelien J M de Jong, Hanneke W M van Laarhoven, Vincent E de Meijer, I Quintus Molenaar, Martijn W J Stommel, Liselot B J Valkenburg-van Iersel, Johanna W Wilmink, Lydia G M van der Geest, Judith de Vos-Geelen,
European Journal of Cancer, 2025, vol. 220
ASO Author Reflections Joseph R. Habib, Ingmar F. Rompen, Camila Hidalgo Salinas, Vincent P. Groot, Ammar A. Javed, Lois A. Daamen
Annals of surgical oncology, 2025, vol. 32, p.2868-2869
Longitudinal health-related quality of life in patients with pancreatic cancer stratified by treatment Anne M. Gehrels, Pauline A.J. Vissers, Mirjam A.G. Sprangers, Nienke M. Fijnheer, Esther N. Pijnappel, Lydia G. van der Geest, Geert A. Cirkel, Judith de Vos-Geelen, Marjolein Y.V. Homs, Geert Jan Creemers, Martijn W.J. Stommel, Lois A. Daamen, Marc G. Besselink, Johanna W. Wilmink, Hanneke W.M. van Laarhoven,
EClinicalMedicine, 2025, vol. 80
Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists J. M. Westerhoff, F. J. Raaijmakers, L. A. Daamen, E. N. de Groot-van Breugel, L. T.C. Meijers, J. R.N. van der Voort van Zyp, J. J.C. Verhoeff, S. Mook, H. M. Verkooijen, M. P.W. Intven
Clinical and translational radiation oncology, 2025, vol. 51
Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer N. C. Biesma, M. U.J.E. Graus, G. A. Cirkel, M. G. Besselink, J. W.B. de Groot, B. Groot Koerkamp, K. H. Herbschleb, M. Los, R. C. Verdonk, J. W. Wilmink, A. Cervantes, J. W. Valle, L. B.J. Valkenburg-van Iersel, F. E.M. Froeling, I. Q. Molenaar, L. A. Daamen, J. de Vos-Geelen, H. C. van Santvoort,
European Journal of Surgical Oncology, 2025, vol. 51